Tau truncation in the pathogenesis of Alzheimer’s disease: a narrative review

Alzheimer’s disease is characterized by two major neuropathological hallmarks—the extracellular β-amyloid plaques and intracellular neurofibrillary tangles consisting of aggregated and hyperphosphorylated Tau protein. Recent studies suggest that dysregulation of the microtubule-associated protein Ta...

Full description

Bibliographic Details
Main Authors: Dandan Chu, Xingyue Yang, Jing Wang, Yan Zhou, Jin-Hua Gu, Jin Miao, Feng Wu, Fei Liu
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2024-01-01
Series:Neural Regeneration Research
Subjects:
Online Access:http://www.nrronline.org/article.asp?issn=1673-5374;year=2024;volume=19;issue=6;spage=1221;epage=1232;aulast=Chu
_version_ 1797231744006488064
author Dandan Chu
Xingyue Yang
Jing Wang
Yan Zhou
Jin-Hua Gu
Jin Miao
Feng Wu
Fei Liu
author_facet Dandan Chu
Xingyue Yang
Jing Wang
Yan Zhou
Jin-Hua Gu
Jin Miao
Feng Wu
Fei Liu
author_sort Dandan Chu
collection DOAJ
description Alzheimer’s disease is characterized by two major neuropathological hallmarks—the extracellular β-amyloid plaques and intracellular neurofibrillary tangles consisting of aggregated and hyperphosphorylated Tau protein. Recent studies suggest that dysregulation of the microtubule-associated protein Tau, especially specific proteolysis, could be a driving force for Alzheimer’s disease neurodegeneration. Tau physiologically promotes the assembly and stabilization of microtubules, whereas specific truncated fragments are sufficient to induce abnormal hyperphosphorylation and aggregate into toxic oligomers, resulting in them gaining prion-like characteristics. In addition, Tau truncations cause extensive impairments to neural and glial cell functions and animal cognition and behavior in a fragment-dependent manner. This review summarizes over 60 proteolytic cleavage sites and their corresponding truncated fragments, investigates the role of specific truncations in physiological and pathological states of Alzheimer’s disease, and summarizes the latest applications of strategies targeting Tau fragments in the diagnosis and treatment of Alzheimer’s disease.
first_indexed 2024-04-24T15:49:14Z
format Article
id doaj.art-6fef2a4444084826a17ec59fd7d262a7
institution Directory Open Access Journal
issn 1673-5374
language English
last_indexed 2024-04-24T15:49:14Z
publishDate 2024-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Neural Regeneration Research
spelling doaj.art-6fef2a4444084826a17ec59fd7d262a72024-04-01T13:05:59ZengWolters Kluwer Medknow PublicationsNeural Regeneration Research1673-53742024-01-011961221123210.4103/1673-5374.385853Tau truncation in the pathogenesis of Alzheimer’s disease: a narrative reviewDandan ChuXingyue YangJing WangYan ZhouJin-Hua GuJin MiaoFeng WuFei LiuAlzheimer’s disease is characterized by two major neuropathological hallmarks—the extracellular β-amyloid plaques and intracellular neurofibrillary tangles consisting of aggregated and hyperphosphorylated Tau protein. Recent studies suggest that dysregulation of the microtubule-associated protein Tau, especially specific proteolysis, could be a driving force for Alzheimer’s disease neurodegeneration. Tau physiologically promotes the assembly and stabilization of microtubules, whereas specific truncated fragments are sufficient to induce abnormal hyperphosphorylation and aggregate into toxic oligomers, resulting in them gaining prion-like characteristics. In addition, Tau truncations cause extensive impairments to neural and glial cell functions and animal cognition and behavior in a fragment-dependent manner. This review summarizes over 60 proteolytic cleavage sites and their corresponding truncated fragments, investigates the role of specific truncations in physiological and pathological states of Alzheimer’s disease, and summarizes the latest applications of strategies targeting Tau fragments in the diagnosis and treatment of Alzheimer’s disease.http://www.nrronline.org/article.asp?issn=1673-5374;year=2024;volume=19;issue=6;spage=1221;epage=1232;aulast=Chualzheimer’s disease; cleavage site; diagnosis; marker; neurofibrillary tangles; phosphorylation; tau; tau aggregation; therapy; truncation
spellingShingle Dandan Chu
Xingyue Yang
Jing Wang
Yan Zhou
Jin-Hua Gu
Jin Miao
Feng Wu
Fei Liu
Tau truncation in the pathogenesis of Alzheimer’s disease: a narrative review
Neural Regeneration Research
alzheimer’s disease; cleavage site; diagnosis; marker; neurofibrillary tangles; phosphorylation; tau; tau aggregation; therapy; truncation
title Tau truncation in the pathogenesis of Alzheimer’s disease: a narrative review
title_full Tau truncation in the pathogenesis of Alzheimer’s disease: a narrative review
title_fullStr Tau truncation in the pathogenesis of Alzheimer’s disease: a narrative review
title_full_unstemmed Tau truncation in the pathogenesis of Alzheimer’s disease: a narrative review
title_short Tau truncation in the pathogenesis of Alzheimer’s disease: a narrative review
title_sort tau truncation in the pathogenesis of alzheimer s disease a narrative review
topic alzheimer’s disease; cleavage site; diagnosis; marker; neurofibrillary tangles; phosphorylation; tau; tau aggregation; therapy; truncation
url http://www.nrronline.org/article.asp?issn=1673-5374;year=2024;volume=19;issue=6;spage=1221;epage=1232;aulast=Chu
work_keys_str_mv AT dandanchu tautruncationinthepathogenesisofalzheimersdiseaseanarrativereview
AT xingyueyang tautruncationinthepathogenesisofalzheimersdiseaseanarrativereview
AT jingwang tautruncationinthepathogenesisofalzheimersdiseaseanarrativereview
AT yanzhou tautruncationinthepathogenesisofalzheimersdiseaseanarrativereview
AT jinhuagu tautruncationinthepathogenesisofalzheimersdiseaseanarrativereview
AT jinmiao tautruncationinthepathogenesisofalzheimersdiseaseanarrativereview
AT fengwu tautruncationinthepathogenesisofalzheimersdiseaseanarrativereview
AT feiliu tautruncationinthepathogenesisofalzheimersdiseaseanarrativereview